Alexandre Zanghellini co-founded Arzeda and serves as its Chief Executive Officer. He leads Arzeda’s corporate strategy, including technology and product development. Alex is one of the inventors of Arzeda’s synthetic biology platform for protein design and metabolic pathway design and is a keen believer in the power of biotechnology to solve some of our biggest societal challenges, especially that of transforming industrial and agricultural processes to be more efficient, sustainable and environmentally friendly. Before founding Arzeda, Alex held positions in research and development both in academia and industry (Cellectis, NASDAQ: CLLS). He holds a Ph.D. in Biochemistry from the University of Washington in Seattle WA, a M. Eng. in computer engineering from ENSTA/ParisTech in Paris, France and a M.S in computer science/machine learning from University of Paris VI Pierre et Marie Curie, France.